Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Sales $ 4,915,240 $ 635,789
Cost of sales (1,211,799) (726,686)
Gross profit (loss) 3,703,441 (90,897)
Operating Expenses    
Selling and marketing 580,850 320,768
General and administrative 5,389,716 4,814,312
Depreciation and amortization 145,653 170,189
Gain from insurance settlement (30,240)
Total operating expenses 6,116,219 5,275,029
Loss From Operations (2,412,778) (5,365,926)
Other Expense (Income)    
Interest expense, net 348,098 245,174
Forgiveness of PPP loan (242,486)
Loss on extinguishment of debt 355,602
Gain on debt restructuring (130,421)
Other income (162,500) (2,100)
Losses (gains) from foreign currency translation 33,128 (52,498)
Total other (income) expense (23,760) 415,757
Net Loss (2,389,018) (5,781,683)
Net loss attributable to non-controlling interest 197,312 133,162
Series B preferred stock dividends (721,752)
Net Loss Attributable to Common Stockholders $ (2,191,706) $ (6,370,273)
Net Loss Per Common Share    
Basic and Diluted $ (0.27) $ (1.48)
Weighted Average Number of Common Shares Outstanding    
Basic and Diluted 8,019,206 4,310,440